Acute Respiratory Distress Syndrome Clinical Trial
Official title:
Extravascular Lung Water Index and Pulmonary Vascular Permeability Index Assessed by the Transpulmonary Thermodilution Method in Patients After Minimally Invasive Cardiac Surgery With Cardiopulmonary Bypass and One Lung Ventilation
The use of cardiopulmonary bypass (CPB) combined with one lung ventilation (OLV) allows to
perform minimally invasive cardiac surgery (MICS) through small incisions. MICS is described
to be associated with similar outcomes compared with conventional surgery. Although less
invasive, MICS has not been reported to favorably impact the incidence of respiratory
failure after surgery.
The combination CPB and OLV may induce acute respiratory distress syndrome (ARDS). After CPB
contact of blood components with the artificial surface of the bypass, lung ischemia
reperfusion injury (LIRI) and operative trauma may trigger a systemic inflammatory response
syndrome (SIRS). During OLV, ARDS can result from hyperoxia, hyperperfusion and ventilatory
distress in the ventilated lung as well as from LIRI and operative trauma of the collapsed
lung.
Extravascular lung water (EVLW) includes all fluids in the lung except for those in the
vascular compartment. An excess of EVLW may lead to respiratory insufficiency. This may be
due to an increased hydrostatic intravascular pressure, as it occurs in cardiogenic
pulmonary edema, and/or by an increase of lung endothelial and epithelial permeability, as
in ARDS. The extravascular lung water index (EVLWI) assessed by the transpulmonary
thermodilution technique may be a useful tool for accurate diagnosis of ARDS, and the
pulmonary vascular permeability index (PVPI) may help in the differentiation between
pulmonary edema due to an increase in the pulmonary capillary permeability versus an
increase in the pulmonary capillary hydrostatic pressure.
As both CPB and OLV may induce an excess of EVLW, the investigators hypothesize that
patients after MICS with intraoperative combination of CPB and OLV may have higher EVLWI and
PVPI than those who received either CPB or OLV alone.
Acute respiratory distress syndrome (ARDS) occur with an incidence of 12% after cardiac
surgery with the use of cardiopulmonary bypass (CBP). Using one-lung ventilation (OLV) in
addition, as it is common practice in minimally invasive cardiac surgery (MICS), one can
hypothesize that the risk for ARDS increases.
The objective of this prospective, observational study is to measure extravascular lung
water index (EVLWI) and pulmonary vascular permeability index (PVPI) as parameters of lung
edema through alteration in the pulmonary permeability by comparing three groups of surgery
patients: I) patients with CPB, II) patients with OLV and III) patients with both CPB and
OLV.
MICS allows coronary artery bypass grafting and cardiac valve surgery through small
incisions, does not appear to be inferior to conventional surgery, but likely reduces
postoperative pain, accelerates postoperative recovery and improves the cosmetic result.
However, based on the available data, respiratory failure after MICS occurs at the same rate
as after conventional cardiac surgery. In addition, unilateral re-expansion pulmonary edema,
rarely seen after conventional cardiac surgery, has been described after MICS with CPB and
OLV.
The pathophysiology of ARDS is characterized by massive inflammation that leads to a diffuse
damage of both the alveolar epithelium and pulmonary vascular endothelium. Although the
etiology of ARDS is multifactorial, the uniform result is an acute, nonhydrostatic,
high-permeability lung injury with interstitial and alveolar protein-rich edema, epithelial
damage and rapid onset of pulmonary fibrosis. This leads to the vast reduction of the
pulmonary gas exchange and to hypoxemia.
Extravascular lung water (EVLW) comprises all fluids of the extravascular compartment of the
lung, ie, intracellular water, lymphatic fluid, surfactant and extravasated plasma.
Increased EVLW may be caused by an increased hydrostatic intravascular pressure, as it
occurs in cardiogenic pulmonary edema, and/or by an increase of lung endothelial and
epithelial permeability, as in ARDS. The EVLWI estimates the EVLW by using the
transpulmonary thermodilution technique.The pulmonary vascular permeability index (PVPI) is
the ratio between the EVLWI and the pulmonary blood volume, which is also measured by the
transpulmonary thermodilution technique. The PVPI is thought to reflect the permeability of
the alveolar-capillary barrier.
The combination of CPB and OLV permitted the development of MICS. CPB is an extracorporeal
circulation, where a heart-lung machine takes over temporarily the pump function of the
heart and the oxygenation and ventilation function of the lungs, thereby, allowing various
heart and vascular surgical procedures. During CPB, blood from the right side of the heart
is drained into the heart-lung machine and returned into the arterial system. This leads to
a hypoperfusion of the lung, while blood flow is maintained only through the bronchial
artery. OLV allows the surgeon to access the thorax cavity for the operation, while
contralateral lung is ventilated.
It was originally thought that the lung is relatively resistant to ischemia due to its dual
circulation. However, re-perfusion of the lung after CPB and/or OLV can trigger a fatal
cascade, summarized as lung ischemia reperfusion injury (LIRI). LIRI involves intracellular
injury and pertinent inflammatory responses, which result in apoptosis of the endothelium,
alveolar capillary interstitial edema, hyaline membranization, and infiltration by
neutrophils and macrophages. In addition, during CPB, the contact of blood components with
the artificial surface of the bypass circuit contribute to the postoperative systemic
inflammatory response syndrome (SIRS). Through these mechanisms, lung compliance and
resistance as well as pulmonary permeability are affected, which contributes to the
development of ARDS. During OLV, a combination of LIRI as well as surgical trauma and lung
hyperinflation may lead to the release of inflammatory mediators which can alter
endovascular permeability. Additionally, after thoracic surgery the pulmonary vascular
permeability increases and re-expansion of the collapsed lungs may result in the so called
re-expansion pulmonary edema.
To the best of the investigators knowledge, no study primarily aimed at examining the
relationship between MICS and lung injury, although it is of high clinical interest whether
the combination of CPB and OLV during MICS leads to increased EVLW and pulmonary
permeability and ARDS.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Recruiting |
NCT05535543 -
Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
|
||
Completed |
NCT04695392 -
Restore Resilience in Critically Ill Children
|
N/A | |
Terminated |
NCT04972318 -
Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia
|
N/A | |
Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
Completed |
NCT04078984 -
Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
|
||
Completed |
NCT04451291 -
Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure
|
N/A | |
Not yet recruiting |
NCT06254313 -
The Role of Cxcr4Hi neutrOPhils in InflueNza
|
||
Not yet recruiting |
NCT04798716 -
The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
|
Phase 1/Phase 2 | |
Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT02881385 -
Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation
|
N/A | |
Terminated |
NCT02867228 -
Noninvasive Estimation of Work of Breathing
|
N/A | |
Completed |
NCT02545621 -
A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
|
||
Completed |
NCT02232841 -
Electrical Impedance Imaging of Patients on Mechanical Ventilation
|
N/A | |
Withdrawn |
NCT02253667 -
Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients
|
N/A | |
Withdrawn |
NCT01927237 -
Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide
|
N/A | |
Completed |
NCT02889770 -
Dead Space Monitoring With Volumetric Capnography in ARDS Patients
|
N/A | |
Completed |
NCT01504893 -
Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia
|
N/A | |
Completed |
NCT01680783 -
Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
|
N/A | |
Completed |
NCT02814994 -
Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients
|
N/A |